FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mylan Pharmaceuticals Capecitabine Tablets Recall

Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc

Mylan Pharmaceuticals Inc · Morgantown, PA

Risk level
Class II
Reported by FDA
Jul 15, 2015
Recall ID
D-1217-2015
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Capecitabine Tablets starting Jun 30, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1217-2015 on Jul 15, 2015. Reason: Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.

Product description

Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.

Lot numbers, UPCs & expiration codes

Lot #: 3053562, Exp 02/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1217-2015
Classification
Class II
Status
Terminated
Recall initiated
Jun 30, 2015
FDA report date
Jul 15, 2015
Quantity
1068 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-1217-2015, exactly as published.

Show all FDA fields
City
Morgantown
State
PA
Status
Terminated
Country
United States
Event ID
71566
Address
781 Chestnut Ridge Rd
Code information
Lot #: 3053562, Exp 02/16
Postal code
19543
Report date
Jul 15, 2015
Product type
Drugs
Recall number
D-1217-2015
Classification
Class II
Recalling firm
Mylan Pharmaceuticals Inc
Product quantity
1068 bottles
Termination date
Sep 22, 2016
Reason for recall
Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.
Distribution pattern
Nationwide
Recall initiation date
Jun 30, 2015
Initial firm notification
Letter
Center classification date
Jul 8, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1217-2015, published Jul 15, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls